Method of Prognosis of Mental Diseases, E.G. Autism and Cerebral Palsy

摘要

The invention provides a method of prognosis for applied behavioral analysis treatment of mental disease, in particular autism or cerebral palsy, in a human subject. The method includes analyzing a sample of body tissue or fluid from the subject for the presence or absence of a chemical marker indicative of the likelihood of success or failure of applied behavioral analysis treatment of the mental disease, and optionally, based on the analysis, beginning, continuing or ceasing applied behavioral analysis treatment of the subject. The sample is preferably an urine sample, and the preferred prognostic markers are: gluten derivatives, indolyl-3-acryloylglycine (IAG), serotonin uptake stimulator, β-casomorphineamides, gliadinomorphine, β-casomorphines, deltorphins, Demorphine, glutemorphine, gluten exophins, compounds of molecular weight of 687 Daltons.